MEDTRONIC PUERTO RICO OPERATIONS CO. ACTIVA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINS
|
Back to Search Results |
|
Model Number 37612 |
Device Problems
Delayed Charge Time (2586); Malposition of Device (2616); Battery Problem (2885); Charging Problem (2892); Communication or Transmission Problem (2896); Impedance Problem (2950)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Type
malfunction
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was reported that the patient had difficulty with recharging.The manufacturer's representative (rep) said the patient seems to not get any more than 4-6 coupling bars and at best, gets up to 50%, normally patient recharges for couple hours and can't get more than 25%; later in the conversation, the rep then mentioned the patient recharging 45 minutes per day.The rep also mentioned that the patient has an impedance issue on electrode #8, showing investigate, but the electrode was not being used for programming.Technical services (ts) recommend meeting with the patient to check the recharge data to investigate further.The rep implied the neurostimulator battery capacity was being diminished and that recharging was poor.Ts also told rep by meeting with the patient, the pocket can be assessed to see if the recharge issue is related to a pocket issue or a recharger issue.2.6 volts 130hz 60usec 1000 ohms 3.6 volts 130hz 80usec 1720 ohms 3.01 weeks low, 4.01 weeks empty.No symptoms were reported.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from the manufacturer representative (rep) reporting they requested an appointment with the coordinator.No response was received.The patient stated that her difficulty recharging has been going on for about a year.She charges everyday sometimes for a couple hours and she stated it hasn¿t gone above 25%.No causes have been determined, no troubleshooting has been performed, and it has not resolved.2022-jan-26 e2 (rep): additional information was received from the manufacturer representative (rep) reporting the coordinator did not respond to requests for more info.She did set up a clinic visit for (b)(6) 2022 to troubleshoot.No other actions taken.Cause has not been determined, issue is unresolved.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from the manufacturer representative (rep) reporting they requested an appointment with the coordinator.No response was received.The rep spoke wit the patient.The patient stated that her difficulty recharging has been going on for about a year.She charges everyday sometimes for a couple hours and she stated it hasn¿t gone above 25%.No causes have been determined, no troubleshooting has been performed, and it has not resolved.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received from the manufacturer¿s representative (rep) reported in their opinion the patient¿s implant was too deep as they had difficulty connecting after several attempts.The consumer was a candidate for the recharger replacement program, but the program was on hold right now.The other option than that would be surgical revision.
|
|
Search Alerts/Recalls
|
|
|